Manhard Kimberly's Form 4 filing
Inhibrx Biosciences, Inc. (INBX) · filed Sep 15, 2026
- Accession no.
- 0001202094-26-000006
- Filed
- Sep 15, 2026, 5:52 PM ET
- Trade date
- Sep 11-15, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $163.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Manhard KimberlyCIK 0001202094 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | SSaleDisposed | −500 | $111.78 | −$55,887.5 | 8,500 | Indirect | |
| Sep 14, 2026 | Common Stock | SSaleDisposed | −500 | $110.26 | −$55,130 | 8,000 | Indirect | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −500 | $105.05 | −$52,525 | 7,500 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.